Narcolepsy | Norton Healthcare

Indication: Narcolepsy

A Double-blind, Randomized, Placebo Controlled, Two Arm Multi-center Study to Assess the Efficacy and Safety of a Once Nightly Formulation of Sodium Oxybate for Extended-Release Oral Suspension (FT218) for the Treatment of Excessive Daytime Sleepiness and Cataplexy in Subjects with Narcolepsy

Pts with Excessive Daytime Sleepiness & Cataplexy

Drug Study

Principal Investigator: David Winslow, M.D.
Norton Pulmonary Specialists, Norton Sleep Center

Sponsor: Flamel Ireland Limited

Email for more information: NCRG@nortonhealthcare.org

Search our entire site.

Schedule an Appointment

Select an appointment date and time from available spots listed below.